Clinical Trials Directory

Trials / Completed

CompletedNCT04890275

Blood Flow Restricted Resistance Training in Peripheral Arterial Disease

Blood Flow Restricted Resistance Training in Peripheral Arterial Disease: a Randomised Controlled Trial Feasibility Study

Status
Completed
Phase
N/A
Study type
Interventional
Enrollment
30 (actual)
Sponsor
Sheffield Hallam University · Academic / Other
Sex
All
Age
18 Years
Healthy volunteers
Not accepted

Summary

A randomised controlled trial evaluating the feasibility and acceptability of a 12 week lower body blood flow restricted resistance exercise programme for people with peripheral arterial disease.

Detailed description

The primary aim of this study is to determine the feasibility of 12 weeks of lower body resistance exercise performed with blood flow restriction (BFR) in people with peripheral arterial disease. Resistance exercise with BFR involves placing inflatable cuffs proximal to the exercise limbs in order to manipulate blood flow and enhance the training response. Secondary aim of this study is to evaluate changes in ABPI, muscle size, strength and physical function at mid-and post- intervention.

Conditions

Interventions

TypeNameDescription
OTHERBlood flow restricted resistance exercise (BFR)Following a 5-minute low intensity warm-up, the BFR cuff will be placed at the most proximal portion of the leg inflated to 50% limb occlusion following standard BFR guidelines. Participants will then perform leg press including 1 set of 30 reps, then 3 sets of 15 reps at 20% 1RM. Rest for 5 minutes without cuff inflation. Cuffs will be re inflated and participants will perform knee extension including 3 x 15 repetitions at 20% 1RM.
OTHERResistance exercise without blood flow restricted (NON-BFR)Participants will follow the same exercise protocol as the blood flow restriction group but with out BFR.

Timeline

Start date
2021-04-21
Primary completion
2022-03-05
Completion
2022-04-30
First posted
2021-05-18
Last updated
2022-11-08

Locations

1 site across 1 country: United Kingdom

Source: ClinicalTrials.gov record NCT04890275. Inclusion in this directory is not an endorsement.